Biotech

All Articles

Repare gives up 25% of personnel as biotech standstills preclinical R&ampD

.Repare Rehab is laying off a fourth of its own workforce as the oncology biotech scales back its pr...

J &amp J apply for FDA permission of $6.5 B autoimmune drug

.Johnson &amp Johnson has gotten another measure towards realizing a gain on its own $6.5 billion ni...

Gain's phase 1 gain paves technique to confirm Parkinson's medicine's worth

.Gain Therapies has prepared its direct proving the effectiveness of its Parkinson's health conditio...

Actinogen files new stage 2 information to salvage depression medication

.Actinogen Medical's hopes-- and supply cost-- have actually recoiled slightly coming from previousl...

Pfizer and also Flagship include Ratio to multibillion-dollar formula

.Crown Jewel Pioneering as well as Pfizer have actually included Ratio right into their 10-program c...

Bayer markers $547M pact to drive perimeters of noncoding RNA

.Bayer execs were eager to tension to Brutal this summer season that the German pharma titan's hunge...

UK introduces plannings to release 18 brand new medical trial centers

.In the middle of a yearslong medical trial downtrend in the U.K., a brand new public-private relati...

UPDATE: Genentech telegraphs 93 layoffs in California after sharing programs to shutter cancer cells immunology analysis system

.Following the announcement of a huge layoff shot in April and also a major restructuring initiative...

Neurocrine's KarXT rival hits in phase 2-- yet simply at low dose

.Neurocrine Biosciences has attained its hoped-for profile in a stage 2 schizophrenia trial, providi...

Vaderis' uncommon blood vessel ailment medication lessens nosebleeds

.Vaderis Therapeutics' goal to build the very first medicine intended specifically at a particular u...